Pivotal Study of the Velocity™ pAVF System | MicrobiomeTrials← Back to trialsNCT07153939
Pivotal Study of the Velocity™ pAVF System
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2025-10-21Est. Completion: 2026-09
Enrollment target: 126 participants Locations- Trinity Research Group, Dothan, Alabama, United States
- West Coast Kidney Institute Concord, Concord, California, United States
- Apex Research, Riverside, California, United States
- Vascular and Embolization Specialists, Cocoa, Florida, United States
- Azura Vascular Care Jacksonville, Jacksonville, Florida, United States
- Staten Island University Hospital Northwell Health, Staten Island, New York, United States
- Surgical Specialists of Charlotte, Charlotte, North Carolina, United States
- MUSC Health Orangeburg- Dialysis Access Institute, Orangeburg, South Carolina, United States
- Aqua Research, Houston, Texas, United States
- Humble Vascular Surgical Center, Humble, Texas, United States
- Fresenius Vascular Care San Antonio, San Antonio, Texas, United States
- San Antonio Surgical Center, San Antonio, Texas, United States
Other microbiome trials you might be interested in
Chronic Hepatitis B e Antigen PositiveChronic Hepatitis B e Antigen Negative
Background:
\- Chronic infection with the hepatitis B virus may lead to cirrhosis, liver disease, and cancer of the liv…
Bethesda, United States
Chronic Kidney Disease-Associated Pruritus in Hemodialysis
This is a randomized, open-label, multi-center clinical study aimed at evaluating the efficacy and safety of 12 weeks of…
Beijing, ChinaEst. completion Dec 31, 2028
An appropriate hypothalamic-pituitary-adrenal (HPA) axis response is required to survive critical illness. Primary adren…